Original Publication Date: 1 January, 2015
Publication / Source: Personalized Medicine
Authors: Dhaval Patil & Amalia M Issa
Aim: In this study, we evaluated the association between oncologists’ perceptions of and attitudes toward one frequently used gene expression profiling assays, the Oncotype DX® and oncologists’ intention to use this assay in making treatment recommendations for breast cancer patients. Methods: A nationally representative sample of breast cancer oncologists was surveyed using an adapted technology acceptance model.